Evgeny Krupitsky, M.D., Ph.D., D.M.Sc.
Excellence in International Leadership, 2010
Evgeny Krupitsky , M.D., Ph.D., D.M.Sc.
Pavlov Medical University and Bekhterev Research
Psychoneurological Institute
St. Petersburg, Russia
Evgeny Krupitsky served as principal investigator for a multi-center Phase 3 clinical trial demonstrating that the alcohol abuse medication Vivitrol is an effective treatment for opioid dependence. Dr. Krupitsky’s work has helped identify the first non-narcotic, non-addictive, long-acting opioid dependence medication, providing a proven opioid pharmacotherapy option for residents of countries that ban other treatment medications. Throughout his career, Dr. Krupitsky has demonstrated an exceptional ability to translate basic science concepts into evidence-based drug policies and treatments. Working with colleagues in Russia and the United States, Dr. Krupitsky conducted the initial clinical epidemiological research on the prevalence of AIDS and its relationship to injection drug use in St. Petersburg, and then translated those findings into improved addiction policies and clinical practices in the region.
Important Dates
NIDA International Forum
June 14–17, 2013
Online Registration Deadline:
May 6, 2013
FELLOWSHIPS
IAS/NIDA Fellowships
Application Deadline:
February 10, 2013
NIDA International Program Fellowships
Application Deadline:
April 1, 2013
Global Health Program for Fellows and Scholars
Application Deadlines: Vary
GRANTS
Brain Disorders in the Developing World: Research Across the Lifespan
(Non-AIDS)
R01 PAR-11-030and R21 PAR-11-031
Application deadline:
February 14, 2013
MEETINGS
American Association for the Advancement of Science
February 14–18, 2013
Boston, Massachusetts, USA
International Drug Abuse Research Society (IDARS)
April 15–19, 2013
Mexico City, Mexico
2013 International Conference on Global Health: Prevention and Treatment of Substance Abuse and HIV
April 17–19, 2013
Taipei, Taiwan
Yih-Ing Hser, Ph.D.